94 filings
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
11 Jun 24
Current report (foreign)
4:30pm
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
25 Apr 24
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
8:03am
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
16 Apr 24
Virax Biolabs Group Limited to Participate at ESCMID Global 2024
7:34am
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
15 Mar 24
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
4:32pm
6-K
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Current report (foreign)
5:28pm
424B5
4xwfiqje dlrap6fqp
22 Jan 24
Prospectus supplement for primary offering
5:27pm
6-K
jnlusa6lvs2dzezt
12 Jan 24
Current report (foreign)
7:43am
6-K
sbjxm6ma5hmk 5bz957
21 Dec 23
Current report (foreign)
7:34am
424B3
wjvvfo
20 Dec 23
Prospectus supplement
4:12pm
6-K
qoc93kx
20 Dec 23
Current report (foreign)
4:06pm
424B3
19ssj8kn98 pu2hhgodo
20 Dec 23
Prospectus supplement
4:03pm
6-K
5kecek1q a70l
18 Dec 23
Virax Biolabs’ CEO James Foster Issues Letter to Shareholders
7:37am
EFFECT
u2jakj8bmlep
18 Dec 23
Notice of effectiveness
12:15am
6-K
238ld jst
14 Dec 23
Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation
7:43am
CORRESP
etxhnikqb kygolu2n
13 Dec 23
Correspondence with SEC
12:00am
UPLOAD
8ybmhx8y
12 Dec 23
Letter from SEC
12:00am
6-K
5hluxaz
8 Dec 23
Current report (foreign)
6:03am
F-3
aooox27 0wuc493p6h
5 Dec 23
Shelf registration (foreign)
4:06pm
6-K
9bgz81m
8 Nov 23
Current report (foreign)
4:11pm
6-K
da6j1t15q 1743val
31 Oct 23
Current report (foreign)
4:38pm